Business·Finance·Health·iOS·News·Space·Startups·Stock Market·Stocks Samsara’s Roller Coaster: A Tale of Soaring Performance and Troubling Forecasts Samsara beat Wall Street expectations with Q4 revenue of $346.29 million, above the predicted $335.6 million. Adjusted EPS reached $0.11, exceeding the by Cameron Anderson 2 months ago
The Financial Engine Powering DiaMedica’s Bold Medical Advancements: Discover the Surprising Numbers 1 day ago
A Small Biotech’s Bold Leap: Can Iterum Therapeutics Transform Millions of UTI Treatments? 2 days ago
The Breakthrough You’ve Been Waiting For: Karyopharm’s New Hope for Myelofibrosis Patients 3 days ago